![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Novavax Awarded $60 Million DOD Contract for COVID-19 Vaccine
Novavax Awarded $60 Million DOD Contract for COVID-19 Vaccine
![Novavax logo](https://www.fdanews.com/ext/resources/test/Drug-Images4/Novavax-logo.gif?t=1590614250&width=430)
The Department of Defense has awarded Novavax $60 million for the manufacturing of its COVID-19 vaccine candidate NVX-CoV2373.
Under the contract, the company will work with U.S.-based biologics contract development manufacturing organizations to manufacture the antigen and adjuvant components of the vaccine.
The funding also includes a delivery of 10 million doses this year that can be used in phase 2/3 clinical trials or under Emergency Use Authorization from the FDA.
Upcoming Events
-
21Oct